Literature DB >> 26670619

Fluorine-18 patents (2009-2015). Part 1: novel radiotracers.

Allen F Brooks1, Lindsey R Drake2, Megan N Stewart2, Brian P Cary1, Isaac M Jackson1, Dale Mallette1, Andrew V Mossine1, Peter J H Scott1,2.   

Abstract

The most commonly utilized PET radionuclide is fluorine-18 ((18)F) because of its convenient half-life and excellent imaging properties. In this review, we present the first analysis of patents issued for radiotracers labeled with fluorine-18 (between 2009 and 2015), and provide perspective on current trends and future directions in PET radiotracer development.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26670619      PMCID： PMC5561792          DOI： 10.4155/ppa.15.36

Source DB:  PubMed          Journal:  Pharm Pat Anal        ISSN： 2046-8954


  98 in total

Review 1.  PDE1 isozymes, key regulators of pathological vascular remodeling.

Authors:  Stefan Chan; Chen Yan
Journal:  Curr Opin Pharmacol       Date:  2011-09-29       Impact factor: 5.547

Review 2.  Amino Acid transporter-targeted radiotracers for molecular imaging in oncology.

Authors:  Fan-Lin Kong; David J Yang
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 3.  Value of 11C-methionine PET in imaging brain tumours and metastases.

Authors:  Andor W J M Glaudemans; Roelien H Enting; Mart A A M Heesters; Rudi A J O Dierckx; Ronald W J van Rheenen; Annemiek M E Walenkamp; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-12       Impact factor: 9.236

Review 4.  PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Authors:  Egesta Lopci; Ilaria Grassi; Arturo Chiti; Cristina Nanni; Gianfranco Cicoria; Luca Toschi; Cristina Fonti; Filippo Lodi; Sandro Mattioli; Stefano Fanti
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

5.  Folic acid conjugates for nuclear imaging of folate receptor-positive cancer.

Authors:  Cristina Müller; Roger Schibli
Journal:  J Nucl Med       Date:  2010-12-13       Impact factor: 10.057

Review 6.  Calpain as a therapeutic target in traumatic brain injury.

Authors:  Kathryn E Saatman; Jennifer Creed; Ramesh Raghupathi
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

Review 7.  Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011).

Authors:  Jiang Wang; María Sánchez-Roselló; José Luis Aceña; Carlos del Pozo; Alexander E Sorochinsky; Santos Fustero; Vadim A Soloshonok; Hong Liu
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

8.  Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β.

Authors:  Damian Brockschnieder; Heribert Schmitt-Willich; Tobias Heinrich; Andrea Varrone; Balázs Gulyás; Miklos Toth; Jan Andersson; Ulf Boemer; Sabine Krause; Matthias Friebe; Ludger Dinkelborg; Christer Halldin; Thomas Dyrks
Journal:  J Nucl Med       Date:  2012-09-24       Impact factor: 10.057

9.  First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.

Authors:  Morten Persson; Hongguang Liu; Jacob Madsen; Zhen Cheng; Andreas Kjaer
Journal:  Nucl Med Biol       Date:  2013-04-18       Impact factor: 2.408

10.  Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.

Authors:  Anthony A Estrada; Xingrong Liu; Charles Baker-Glenn; Alan Beresford; Daniel J Burdick; Mark Chambers; Bryan K Chan; Huifen Chen; Xiao Ding; Antonio G DiPasquale; Sara L Dominguez; Jennafer Dotson; Jason Drummond; Michael Flagella; Sean Flynn; Reina Fuji; Andrew Gill; Janet Gunzner-Toste; Seth F Harris; Timothy P Heffron; Tracy Kleinheinz; Donna W Lee; Claire E Le Pichon; Joseph P Lyssikatos; Andrew D Medhurst; John G Moffat; Susmith Mukund; Kevin Nash; Kimberly Scearce-Levie; Zejuan Sheng; Daniel G Shore; Thuy Tran; Naimisha Trivedi; Shumei Wang; Shuo Zhang; Xiaolin Zhang; Guiling Zhao; Haitao Zhu; Zachary K Sweeney
Journal:  J Med Chem       Date:  2012-10-15       Impact factor: 7.446
View more
  2 in total

Review 1.  Fluorine-18 patents (2009-2015). Part 2: new radiochemistry.

Authors:  Andrew V Mossine; Stephen Thompson; Allen F Brooks; Alexandra R Sowa; Jason M Miller; Peter Jh Scott
Journal:  Pharm Pat Anal       Date:  2016-09

2.  Copper-Mediated Late-stage Radiofluorination: Five Years of Impact on Pre-clinical and Clinical PET Imaging.

Authors:  Jay S Wright; Tanpreet Kaur; Sean Preshlock; Sean S Tanzey; Wade P Winton; Liam S Sharninghausen; Nicholas Wiesner; Allen F Brooks; Melanie S Sanford; Peter J H Scott
Journal:  Clin Transl Imaging       Date:  2020-05-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.